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Abstract
In this chapter, a novel microfluidic device (MagneChip) is described which comprises
microliter  volume reaction chambers filled with magnetically fixed enzyme-coated
magnetic nanoparticles (ecMNPs) and with an in-line UV detector. In the experiments,
MNPs with  phenylalanine  ammonia-lyase  (PAL)—an enzyme which  catalyzes  the
deamination of l-phenylalanine (Phe) to (E)-cinnamate in many organisms—immobi‐
lized on the surface were applied as biocatalyst  to study the characteristics of  the
MagneChip device. In the reaction chambers of this microfluidic device, the accurate in
situ quantization of the entrapped MNPs was possible using a resonant coil magneto‐
meter integrated below the chambers. Computational fluid dynamics (CFD) calcula‐
tions were used to simulate the flow field in the chambers.  The enzyme-catalyzed
biotransformations could be performed in the chip with excellent reproducibility and of
repeatability. The platform enabled fully automatic multiparameter measurements with
a single biocatalyst loading of about 1 mg PAL-ecMNP in the chip. A study on the effect
of particle size and arrangement on the catalytic activity revealed that the mass of ecMNPs
fixed in the chamber is independent of the particle diameter. Decreasing the particle size
resulted in increasing catalytic activity due to the increased area to volume ratio. A binary
mixture of particles with two different particle sizes could increase the entrapped particle
mass and further the catalytic activity compared to the best uniform packing. The platform
enabled a study of biotransformation of L-phenylalanine and five unnatural substrates
by consecutive reactions using same PAL-ecMNP loading. With the aid of the platform,
we first demonstrated that PAL can catalyze the ammonia elimination from the noncyclic
propargylglycine as substrate.
Keywords: Magnetic nanoparticles, Magnetic chip reactor, Microfluidic reactor,
Enzyme reaction, Phenylalanine ammonia-lyase
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1. Introduction
Microreactors are usually defined as miniaturized reaction systems fabricated using methods
of microtechnology and precision engineering. The term “microreactor” is the proposed name
for a wide range of devices, having typically submillimeter channel dimensions which can be
further divided into submicron sized components, for example, microparticle and nanoparti‐
cle carriers [1].
Before evolution of microreactor technology, the traditional way to conduct solution phase
synthesis and analysis was the batch mode in stationary reactors with stirring or shaking to
mix the reactants. Nowadays, microstructured devices offer greatly enhanced performance
compared with conventional batch systems due to effects arising from the microscale domain:
• Batch processes are space-resolved; therefore, the process must be readjusted in each
demand for larger product quantities. In contrast, flow microreactor processes are time-
resolved; therefore, the output of the reaction is determined by the flow rate and the
operation time, and no further optimization is needed. This also leads to accelerated process
development and enhanced safety due to smaller reactor volumes [2].
• Microreactors with high surface-to-volume ratio (SVR) are able to absorb the heat evolv‐
ing in an exothermic reaction more efficiently than any batch reactor. Therefore, the
temperature distribution inside the microreactor is homogenous in the whole volume. In
contrast, small SVR usually leads to uneven temperature distribution in large-scale batch
reactors, decreasing the product yield [2].
• Mixing quality is crucial for many reactions, where the molar ratio between the reactants
needs to be controlled precisely. Short diffusion paths provide efficient mixing in micro‐
reactors, which overrides the achievable mixing efficiency of batch reactors [2].
• In biocatalytic applications, the efficiency of the microreactor can be further improved by
immobilization of enzymes on nanoscale carriers accommodating in the reactor. Reusabil‐
ity of the biocatalyst makes the process economical and more environmentally friendly.
• To perform similar analyses in shorter timescale even in parallel is an anticipated objec‐
tive for screening and routine use in protein and enzyme research [3]. A desirable goal is
the high throughput screening of enzymes and their substrates and inhibitors. The pro‐
spective fields of application of microreactors are quite wide and include biotechnology, as
well as combinatorial chemistry and enzyme-targeted drug discovery [4].
• Analytical systems which comprise microreactors are characterized by outstanding
repeatability and reproducibility, due to replacing iterative steps in batch and discrete
sample treatment by flow injection systems [4]. Benefitting from system automation, this
also eliminates errors associated with manual protocols.
• Small reagent volume is also a benefit of microreactors enabling economical and efficient
screening of novel reaction paths and substrates.
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• Microreactors have a high potential in industry, as developments by microreactors can be
faster transferred into production at lower costs than batch processes.
Despite of the rapid development of enzymatic microreactors in the recent decade, impor‐
tant design questions still need to be answered.
Reaction kinetics is a key parameter of device design. Widely used kinetic parameters are
deduced from the Michaelis–Menten model, which is valid only in batch reactions. In flow
systems, the flow effects should be also considered. Immobilization of the enzymes causes
further complication in modeling. Immobilization may affect the intrinsic kinetic parameters
and may influence the availability of the enzyme. The kinetic model should also consider that
the liquid phase containing the substrate and product is moving compared to the solid phase
containing the immobilized enzyme.
When supported catalyst-filled microreactors are used, reproducible filling of the supported
catalyst into the reactor space is not always straightforward. Even more challenging is the
quantification of the actual load of the carriers.
Long-term stability of the reactor and the reproducibility of the measurements may be affected
—among other factors—by the flow rate, the substrate concentration, and the morphology of
the immobilized biocatalyst.
This chapter presents results carried out by a microfluidic microreactor system, the so called
MagneChip platform including four serial reaction chambers with individually removable
permanent magnets. The results were achieved by experiments using phenylalanine ammo‐
nia-lyase (PAL) from Petroselinum crispum immobilized on the surface of magnetic nanoparti‐
cles (MNPs) and filled into one or more chamber of the MagneChip.
Biotransformations with PAL under different conditions were performed mostly using the
natural substrate L-phenylalanine to study
• the reproducibility of biotransformation in the microreactor system,
• the effects of the long-term use and cyclic reuse of the biocatalyst on the biocatalytic activity,
• the effects of the particle size on the biocatalytic activity,
• the optimal substrate concentration and flow rate of the in-chip biotransformation,
• the effect of immobilization and the use of flow microreactor on the kinetic constants, and
• the biotransformations of further substrates with PAL.
2. Background
2.1. Microreactors
Analytical systems which comprise microreactors are characterized by outstanding repeata‐
bility and reproducibility, due to replacing batch iterative steps and discrete sample treat‐
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ment by flow injection systems [4]. The possibility of performing similar analyses in parallel
is an attractive feature for screening and routine use [3]. Microreactors have been integrated
into automated analytical systems, as well as providing benefits from system automation, and
this also eliminates errors associated with manual protocols [4].
Applications of microreactors can be divided into three classes [4]:
• Organic synthesis, when a target molecule is formed from components in flow
• Analytical use of biocatalysts to transform an analyte difficult to measure to an easy to
measure form
• Screening of substrates and enzymes examines their kinetic characteristics
Microreactor systems can be further divided into classes based on the physical localization of
the catalyst:
Laminar flow reactors: The majority of the commercial flow synthesis systems utilize laminar
flow with soluble components and enzymes [5]. Losing the catalyst is a major drawback of this
technique.
Figure 1. Lab-on-a-chip microreactors: (a) a monolith silica reactor [8], (b) a packed bed silica reactor [9], and (c) a
packed bed MNP reactor [10]. Stability of immobilized enzymes: (d) after reuse of asparaginase in 10 cycles, 10 min
each [7] and (e) during long-term operation of immobilized GOD [8].
Filled reactors: Microreactors utilizing immobilized catalysts (e.g., enzymes) have many
advantages over the traditional flow reactors. First of all, the catalyst (enzyme) can be recycled
after usage; therefore, the process is more economical and environmental friendly. The
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reactions are highly reproducible as the catalyst (enzyme) concentration is fixed in the system.
Immobilization of enzymes often causes decrement in biocatalytic activity and choosing the
appropriate immobilization technique is challenging [6]. It was reported that immobilized
asparaginase retained 95.7% of its activity after 10 cycles of use [7] (Figure 1d), while immo‐
bilized glucose oxidase enzyme (GOD) retained 97% of its original activity after cyclic
regeneration and reuse [8]. Immobilization often extends the long-term stability and temper‐
ature resistance of the enzymes, and in several cases, even the catalytic activity is increased
compared with the soluble form. Immobilized asparaginase retained the 72.6% of its original
activity for 10 weeks [7], and immobilized GOD retained the 95% of its activity [8] (Figure 1e)
for 30 days.
The reactors filled with immobilized (bio)catalyst can be further divided into two groups
according to the type of the supporting material of the (bio)catalyst:
• Monolith reactors: The reactor is defined as monolith reactor where the supporting materi‐
al is fixed in the reactor volume, and the (bio)catalyst is nonremovable; therefore, the chip
is single use. Nanostructured materials are used to further increase the SVR. Examples
include silica monolith reactors [8] (Figure 1a) or most recently reactors incorporating
nanofibrous material made by electrospinning [11].
• Packed bed reactors: The reactor is defined as packed bed reactor where the supporting
materials are beads, even on microscale or nanoscale. The (bio)catalyst is immobilized onto
their surfaces. Nanotechnology enables functional modifications of the beads, for example,
making them magnetic. The reactor can be loaded with the suspension of the beads
(Figure 1b) and viscous [9] or magnetic [12, 13] forces are utilized to keep the particles fixed
in the reaction chamber.
Kinetic studies could be carried out with ease in microreactors by changing the attributes of
the reaction, for example, the inflow substrate concentration. Because the most often used
Michaelis–Menten model cannot be applied to flow reactors; in several cases [9, 14], the Lilly–
Hornby model [15] was applied. Dependency of the kinetic parameters on the flow rate—and
occasionally on further other parameters—was reported in many cases implying the limita‐
tions of the Michaelis–Menten model [8, 9, 14, 16].
In every on-chip study, Km and kcat as kinetic parameters were determined using various ways
of product quantification such as capillary electrophoresis (CE) [7], amperometry [8], and
fluorescent imaging [9, 16].
References Enzyme Method Reusability Stability Particle [E] measurement
Mu et al. [7] Asparaginase Michaelis–
Menten,
LB plot
10 cycles
100 min
10
weeks
MNP Out of chip
Km, Vmax
CE out of chip
95.70% 72.60% 12 nm Supernatant
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References Enzyme Method Reusability Stability Particle [E] measurement
He et al. [8] GOD Michaelis–
Menten,
EH plot
97% 30 days Monolith
reactor
Out of chip
Km, kcat
Amperometry,
on-chip
95% silica Absorbance
Kerby et al. [14] Alkaline
phosphatase
Lilly–Hornby N/A N/A Silica
Microbeads
In chip
Km, kcat
Fluorescent
imaging
Optical
Slovakova et al. [16] Trypsin Michaelis–
Menten,
LB plot
80% N/A MNP Approximated
Km, kcat 600 nm
Seong et al. [9] Lilly–Hornby N/A N/A Microbeads Optical
Km Fluorescent
imaging
15 μm
Table 1. Lab-on-a-chip microreactors with immobilized enzymes.
2.2. Magnetic nanoparticles in microreactors
The importance of MNPs as potential carriers of biomolecules is growing rapidly in biotech‐
nology and biomedicine. In LoC systems, nanosized magnetic particles provide quasi-
homogeneous systems, high dispersion, high reactivity, low diffusion limits, and possibility
of magnetic separation. The MNPs are usually collected in microsized reaction chambers. The
collection and separation from the fluid stream are accomplished by external magnetic field.
Such microreactors were found to be highly effective in biodetection [24], biocatalytic [17], and
bioanalytical [18] applications (Table 1).
Magnetite nanoparticles exhibit superparamagnetic or soft ferromagnetic behavior with high
saturation magnetization resulting in high permeability values [19]. To date, magnetic
manipulation of magnetic beads utilizing a magnetic bead separator array seems to be one of
the most promising technique of precise handling of biocatalysts in chip. Do et al. [12]
developed a microfluidic platform, where the magnetic field was concentrated between
permalloy patterns (50 × 100) to produce a high magnetic field gradient over the edges of them,
thus being able to trap the magnetic beads. Li et al. [13] used external hard magnet to develop
a concentrated magnetic field perpendicular to the channel at a certain position of the chip.
The particles accumulated at the designated place. Slovakova et al. [16] used a pair of hard
neodymium magnets positioned in a given angle to develop a magnetic field parallel to the
channel structure. It was reported that in this case, the particles are arranged parallel with the
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channel axis, and also, the reaction efficiency was reasonably higher than in orthogonal
configurations. Lien et al. [10] used an integrated electromagnet with active cooling for the
entrapment of the magnetic particles in the reaction chamber (Figure 1c).
Because of the widespread applications of MNPs in biotechnology, biomedical, and material
science, more and more synthesis techniques have been developed to obtain different kinds
of MNPs. Exhaustive discussions on the available synthesis techniques (e.g., coprecipitation,
microemulsion, thermal decomposition, solvothermal, sonochemical, microwave assisted,
chemical vapor deposition, combustion synthesis) can be found in several reviews [20, 21]. The
synthetic methods will determine the shape, the size distribution, size, the surface chemistry
of the particles, and consequently their magnetic properties. Various optimization methods
could be used to obtain proper MNPs suitable for the desired research and commercial
applications [21].
In our study, the surface of MNPs was chemically modified by sol–gel method, which resulted
in the formation of a core–shell silica-MNP carrier. Then, the surface was functionalized by
epoxy groups, which were able to form stable, covalent binding with the amino, thiol, or
hydroxide groups of the enzyme. The immobilization of PcPAL was carried out in liquid phase.
For a detailed description, see [18]. After immobilization, negligible protein contents in the
supernatants of the washing procedure were determined by the Bradford assay method [22].
The resulted enzyme-coated magnetic nanoparticles (ecMNPs) were used in two size varia‐
tions, with 250 and 600 nm diameters. Where otherwise not indicated the nominal ecMNP
diameter is 250 nm.
3. The MagneChip platform: construction and operation
MagneChip is a microfluidic platform centered on a chip consisting of several reaction
chambers enabling accumulation (and release) of MNPs. This magnetic microreactor chip can
utilize the benefit of excellent separation ability of MNPs in magnetic field. In various
applications, the MNPs covered by biologically active molecules (e.g., bioreceptors) are
immobilized on their surfaces may be used. Magnetic techniques enable anchoring the
particles inside certain compartment of microreactors, where the accumulated magnetic
particles can form a dense layer. After filling (in a consecutive step), reagents can flow through
the chip, while bioreaction occurs inside the microchambers and the resulted product flows
through the chip. The outflow can be collected and/or quantified outside the chip, for instance
by absorbance method. Because the enzyme to be immobilized on the MNP surfaces can be
chosen freely, a wide variety of applications are possible (Figure 2). Taking the advantage of
the continuous-flow operation, product formation can be monitored for a long time under
various conditions over the same anchored ecMNP layer. MagneChip can be reinitialized
periodically which enables multiparameter experiments, and therefore, reaction kinetics can
be characterized in a fully automated way. Because the flow control system of the platform
allows changing the actual substrate over the ecMNP layer, reactions can be screened even
with unexplored substrates (Scheme 1). This feature renders MagneChip as a tool for substrate
discovery as well.
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Figure 2. Possible applications of MagneChip platform. Reaction chambers are filled with bio-functionalized magnetic
nanoparticles, product formation is measured by in-line UV detector.
Scheme 1. Ammonia elimination from different amino acids (1a-f) catalyzed by PcPAL immobilized onto MNPs with‐
in the MagneChip.
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3.1. Basic aims and principles
A microfluidic test bench was developed for carrying out microreactor experiments with
MagneChip (Figure 3). The test bench consisted of two syringe pumps for dispensing reagents,
a thermostable chip holder and a zoom microscope for the optical inspection of the chip. The
chip holder had four magnet drawers enabling to push permanent magnets under reaction
chambers of the chip and also pull them out as the magnetic field is no longer required.
Figure 3. Schematic diagram of the fluid control system of MagneChip platform [22].
MagneChip reaction chambers (volume of ~1 μl) were designed to accomplish the following
requirements:
• Because (bio)chemical reaction occurred inside the reaction chambers operating under
continuous-flow conditions, a relative homogenous flow velocity distribution was re‐
quired. This condition could be fulfilled because laminar flow was developed in the
chamber.
• MNPs were accumulated in the chambers, and their drifting was prevented by an exter‐
nal magnetic field. The critical flow rate and the amount of accumulated ecMNPs could be
increased using prolated channels providing sufficient amount of (bio)catalysts to reach
reasonable conversion of the desired reaction.
• A resonant coil magnetometer was installed under the reaction chambers. Using the
magnetometer, the accumulated amount of ecMNPs could be measured with high accuracy.
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A four reaction chamber MagneChip layout is presented in Figure 4a. CFD simulations
revealed that the flow velocity distribution inside of the chambers varied in a scale of two
(Figure 4b). Depending on the typical flow rates used in MagneChip, reaction residence time
in the chambers may vary from 1 to 10 s (Figure 4c).
Figure 4. (a) Layout of the four chamber MagneChip; (b) flow velocity distribution inside the reaction chambers (units
are in mm s−1); (c) residence time vs. flow rate in MagneChip reaction chambers.
3.2. Construction method of MagneChip
Figure 4a depicts the arrangement of a four-chamber chip used for testing the enzymatic
reactions.
The chip was constructed by PDMS molding technology. SU-8 photoresist structures were
prepared as a molding master, resulting in a channel height of 110 μm. PDMS was poured on
the master and was kept on room temperature for 1 day. After cross-linking, the PDMS replica
was released and the PDMS channel bodies were bonded to standard microscope glasses after
oxygen plasma treatment. Some of the chips were equipped with a resonant coil magnetome‐
ter placed under the chambers for MNP quantity measurement [23]. The coil was embedded
in an intermediate PDMS layer. For further construction details, see [23].
3.3. Method of MNP quantification in the reaction chambers
The magnetic behavior of MNPs initiated the development of an inductive method to quantify
the nanoparticles. The measurement is based on the resonance frequency shift of a passive
electrical resonant circuit, where a flat inductor coil integrated in a silicone elastomer film acts
as a sensor. From the suspension of MNPs flowing into the chip, MNPs were anchored within
the reaction chambers by external permanent magnets. The ecMNP amount inside the chamber
affected the inductance; therefore, the resonance frequency was changed. The method also
enabled on-line monitoring of the actual ecMNP quantity in the chamber. This test arrange‐
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ment enabled to study the effect of particle size and arrangement on the chamber filling MNP
mass and also on the catalytic activity of the PAL bound to the ecMNPs [23].
3.4. Operation methods of MagneChip
3.4.1. Fluid handling steps
The experiments in MagneChip (Figure 3) involved four steps: (1) filling up the chip with
MNPs, (2) absorbance calibration, (3) experiment cycles, and (4) chip cleaning.
Chip filling. In the chip-filling step, an MNP suspension was driven through the chip by
applying a slight air pressure (0.2–0.3 bar) to the vial containing the MNP suspension and
connected to the inlet of MagneChip via a PTFE tube (Figure 3) at 25°C. During the filling
process, the MNPs were accumulated in the reaction chambers due to the permanent mag‐
nets placed in moveable drawers enabling “on/off” switching of the magnetic field. Once the
chamber most distant from the inlet (Figure 3, Chamber 4) was saturated, the permanent magnet
of the chamber at preceding position was turned on (Figure 3, Chamber 3). The same proce‐
dure was repeated (Figure 3: Chambers 2 and 1) until all chambers were filled up. Each chamber
of the MagneChip device could capture ca. 250 μg of ecMNP biocatalyst [23].
Calibration and experiment cycles: During the forthcoming steps, the valve at the inlet of the
MagneChip (Figure 3) was switched to the substrate (reagent) circuit. The flow controller
performed the dosage of the substrate and other chemicals as dictated by the programmed
sequence.
Chip cleaning: At the final, chip-cleaning step, the magnetic drawers of the MagneChip
(Figure 3) were drown out and a washing solution was driven through the chip to remove
ecMNPs.
The individual steps in a series of experiments, called experiment cycle (Figure 3, Experiment
cycles), involved a Reaction step and a Re-initialization step. A series of experiments could consist
of several experiment cycles depending on the number of parameters to be changed.
Reaction step. In a Reaction step, a substrate-containing solution was flowing through the chip
at a constant flow rate, and the specific absorbance of the product was continuously moni‐
tored in the outflow of the chip.
Re-initialization step. In the Re-initialization step, the feed of the substrate-containing solution
was stopped, and the chip was flushed with a washing buffer, while the magnetic particles
were retained by the permanent magnets.
3.4.2. Reaction step variants
The substrate feed (with continuous monitoring of the absorbance in the outflow at a previ‐
ously selected wavelength) was accomplished according to one of the following variants. The
cycle ended when the predesigned step time had been passed or when the reaction reached
saturation.
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• Repeatibility test. The feed of the substrate started (1st cycle) or continued at unchanged flow
rate.
• Flow rate test. The feed of the substrate started (1st cycle) or continued, while the flow rate
changed cycle by cycle.
• Substrate concentration test. The substrate-containing solution and the washing buffer were
feed in parallel at a predesigned ratio resulted in a predefined dilution of the substrate at
the chip inlet. The dilution ratio could be different cycle by cycle.
• Substrate screening. The actual substrate was loaded into the substrate syringe through a
bypass valve from the actual container of the substrate stock (A-F, in Figure 3), and the feed
of the substrate began at a predefined flow rate. To change to the next substrate, a Re-
initialization step was performed, followed by loading the next substrate into the substrate
syringe from the substrate stock (A-F).
3.5. Quality assessment of the operations in MagneChip
A series of subsequent measurements performed by the system were considered as reliable if
all the following conditions were met [22]:
• independent measurements were reproducible using the same type of ecMNP biocatalyst,
• the product of the enzyme reaction could be measured selectively in the UV–Vis range,
• product and substrate could be completely removed through the washing steps,
• the enzymatic activity of the ecMNP biocatalyst remained unchanged during the measure‐
ment
• and last but not least, the ecMNP layer in the magnetic reactors remained unharmed during
the measurement cycles.
In order to test the fulfillment of the first group of conditions, a control measurement was
performed after each series of experiments; that is, the first step of the sequence was repeat‐
ed in the last step under the same conditions, and the specific activity of the immobilized
biocatalyst (UB) at saturation concentrations of L-phenylalanine (L-1a in Scheme 1) in the first
and last cycles was compared.
3.5.1. Reproducibility of the individual measurements
Reproducibility of the chip-filling process: The first single chamber of the MagneChip was filled
with MNP suspension. Biotransformation of L-1a to 2a (Scheme 1) was performed in flow-
through mode and monitored by in-line UV–Vis. After reaching the stationary state (i.e.,
constant level of product formation), the magnet of the chamber was released and the ecMNPs
were captured in the next chamber. The experiments performed in three consecutive cham‐
bers were repeated three times resulting in UB = 8.01 ± 0.14 μmol g−1 min−1 [22].
The filling–refilling results indicated that neither that the homogeneity of the MNP suspen‐
sion nor the filling procedure of the chambers had remarkable effect on the reproducibility of
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the measurements. The significant difference between the UB values of MNP biocatalyst in
shake vials and in MagneChip indicated increased effectivity of the biocatalysts in MagneChip
device [22].
Reproducibility of independent measurements: Biotransformation of L-phenylalanine (L-1a) to (E)-
cinnamic acid (2a) by MNP biocatalyst suspension (Scheme 1) was performed in shake vial as
three parallel reactions and resulted in UB = 2.91 ± 0.08 μmol g−1 min−1 ensuring that the
homogeneity of the MNP suspension was sufficient [22].
3.5.2. Optical inspection of the reaction chambers
During the experiments, the chip was optically inspected by a zooming microscope and a
monochrome hi-speed smart camera. Before evaluating the measurement sequence, the plan
view of the chip was stored as a reference (∏ref). At the end of the step i of the measurement
sequence, the plan view of the chip was sampled again (∏seq,i) and it was compared to the
reference as follows [22]:
Figure 5. MagneChip device with four MNP-filled and external magnet-equipped microchambers (top left) and SEM
image of the MNP layer (top right). The effect of air bubble passage through the reaction chamber [(a)–(f)]: (a) photo‐
graph, before passage; (b) difference image (difference score SC = 5073), after passage; (c) calculated flow velocity field
before and (d) after the passage; (e) velocity profile in the middle cross section of the chamber before and (f) after the
passage [22].
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where (j,k) are the pixel coordinates of the plan view image; therefore, the changes in accord‐
ance to the reference image are indicated by white pixels. The total number of white pixels is
defined as chamber difference score (SC) used as a marker for describing the changes of the MNP
layer arrangement. Therefore, the changes compared with the image of the first cycle
(reference) were indicated by white areas during the consecutive cycles of the measurement.
In practice, SC values under 2000 reflected to negligible changes. However, SC > 3000 indicated
serious structural change of the ecMNP layer, for instance, the complete breakthrough of a
bubble (Figure 5b) [22]. Air bubbles usually did not split at the channel entrance, rather passed
at one side along the chamber wall. Numerical simulations revealed (Figure 5c–f) that the
velocity profile became asymmetric due to the bubble passage and the overall mass flow rate
through the porous MNP layer significantly decreased (28.6–20.7 μL min−1, roughly 72% of its
original value), while the remaining fluid passed through the developed tunnel. The passing
bubble could drift away particles which decreased the total mass of the biocatalyst in the
reaction chamber. Therefore, the biocatalytic activity of the damaged chamber decreased and
the consequent measurements were no longer reliable.
Reliability assessment of the measurements was based mostly on the following parameters:
1. Chamber difference score (SC)—Over SC > 4000 (average), the measurement was declined.
2. Control measurement—Over 5% of error, the measurement was declined.
Each of the experiments carried out by the platform was justified based on the above criterion.
3.5.3. Reproducibility of cyclic reactions
Figure 6. Time plot of the periodic absorbance change during the cyclic measurement (attempt 1, stable layer). The
chip is re-initialized between the reaction steps (reaching zero absorbance) by washing out substrate and product com‐
pletely [22]. The last measurement served as a control.
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A crucial feature is the reproducibility of cyclic reactions performed by the system. To check
the reproducibility of the test reactions, the MagneChip was filled with MNP biocatalyst, and
biotransformation of L-1a to 2a was performed in seven consecutive cycles, while the chip was
re-initialized during the steps by washing out the substrate and product completely [22]. The
absorbance plot at 290 nm in Figure 6 with the aid of the previously measured extinction
coefficient of the product (2a) indicated the concentration changes of 2a.
The product quantity in cycle by cycle—calculated by taking the integral of the absorbance
plot—clearly indicated that the chip was successfully re-initialized in every cycle through‐
out the experiment, and the reaction was repeated reproducibly seven times (average product
quantity of P = 0.12 ± 1.5% μmol) [22]. The moderate mean value of the chamber difference
score SC = 1322 (1609 max) reflected negligible changes in the MNP layer.
4. The MagneChip platform: application examples
4.1. Characterization of the PAL reaction with L-phenylalanine (L-1a) in MagneChip
4.1.1. Influence of the substrate flow rate on the biotransformation
Figure 7. Dependence of the reaction rate of L-1a conversion to 2a on the flow rate in MagneChip filled by ecMNP.
Saturation was reached at 25 μL min−1 [22].
MagneChip was filled with ecMNP biocatalyst, and biotransformations of L-1a to 2a (Scheme 1)
at various flow rates were performed in seven consecutive cycles, while the chip was re-
initialized at the end of each cycle and a new substrate flow rate was set between 3.6 and 28.6
μL min−1. The first (reference) measurement was repeated in the last cycle as a control. The
negligible difference of specific biocatalytic activity (UB) between the reference and control
measurements (only 3%) and low SC score (SC < 338) indicated that the shear forces did not
caused irreversible changes on the biocatalytic activity even at high flow rate (up to 28.6 μL
min−1) [22].
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The reaction velocity was calculated for each cycles. By increasing the flow rate, the calculat‐
ed reaction velocity increased until reaching saturation at about 25 μL min−1 (Figure 7).
4.1.2. Calculation of kinetic parameters
MagneChip was filled with ecMNP biocatalyst, and biotransformations of L-1a to 2a (Scheme 1)
at various concentrations of L-1a (S0) were performed in 10 consecutive cycles, while the chip
was re-initialized at the end of each cycle and a new substrate concentration was set. It was
found that the reaction followed the first-order kinetics up to (S0) = 3 mM and saturated roughly
at (S0) = 20 mM [22].
The linear fitting method proposed by Lilly et al. [15] was applied for the calculation of the
kinetic constants of the biotransformation of L-1a to 2a in the MagneChip (Figure 8, bottom).
The values of the kinetic constants are summarized in Table 2 [22].
Figure 8. (a) Dependency of the substrate concentration on reaction velocity in MagneChip for the transformation of
L-1a to 2a by MNP biocatalyst. Saturation concentration was reached at 20 mM. (b) Linear fit based on the Lilly–Horn‐
by model [15] to determine Km (resulting in Km = 2.5 mM) [22].
Kinetic parameter MagneChip Shake vial
Km (mM) 2.5 9.1
kcat (s−1) 2.8 × 10−2 3.2 × 10−2
kcat/Km (s−1 M−1) 11.3 3.5
Tablee 2. Kinetic constants in biotransformation of L-1a to 2a with MNP in shake vial and in MagneChip [22]
It was found that the apparent Km value was reasonably smaller in MagneChip (2.5 mM) than
in shake vial (9.1 mM). Turnover number (kcat) and specificity constant (kcat/Km) were deter‐
mined also for both reaction modes. While in the shake vial, the turnover number was
somewhat higher (3.2·× 10−2 s−1) than the in chip (2.8·×·10−2 s−1), the specificity constant turned
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out to be significantly higher in chip (11.3 s−1 M−1) as compared with the shake vial (3.5 s−1 M−1).
This may be attributed to the smaller Km value in the MagneChip indicating significant
contribution of diffusion effects to the higher apparent Km value in shake vial.
4.2. Effect of particle size on the enzyme activity
The accumulated quantity of ecMNPs in the reaction chambers was determined by the
embedded resonant magnetometer of the MagneChip device [23]. The measurements revealed
that the total mass of the accumulated particles was approximately the same for two differ‐
ent particle sizes (m = 241.6 μg, ecMNP600, d = 600 nm and m = 248.3 μg, ecMNP250, d = 250 nm)
[23]. The total particle mass could be only increased using a binary mixture (m = 283.6 μg,
MNP250:600) of the particles. This experiment resulted in a significantly higher MNP mass (17%)
captured in the magnetic chamber as compared with the chamber capacity filled with MNPs
of uniform particle sizes [23].
MagneChip was filled with different sized MNP biocatalysts, and biotransformations of L-1a
to 2a (Scheme 1) were also performed [23]. Compared with the larger particles (ecMNP600), the
total surface area increased both in the ecMNP250 (2.5 times) and the mixture cases (2.06 times).
Note that differences in biocatalytic activity can be expected only due to changes of trans‐
port limitations as the enzyme to MNP mass ratio was kept to be constant of 15% in both cases.
Figure 9. Specific absorbance of cinnamic acid (2a) at 295 nm at the chip outlet using MNP600, MNP250, and 1:1 mixture
of the two kind of particles in the chip [25].
Results of the measurement using variously sized ecMNPs as biocatalysts are summarized in
Figure 9. In fact, the ecMNP600-filled chambers yielded the lowest final concentration of product
as indicated by the lowest specific absorbance (AU = 1.07, at 295 nm) at the chip outlet. Filling
the chip by ecMNP250 resulted in an increase of the measured absorbance by 46% (AU = 1.56,
at 295 nm). Because the chambers contained the same filling mass (m = 241.6 μg for ecMNP600
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and m = 248.3 μg for ecMNP250) and therefore the same enzyme amount, the difference between
the MNP250- and the MNP600-filled reactors can only be attributed to other factors, for exam‐
ple, to the differences in total surface area [23].
The major difference can also stem from the remarkably smaller average microchannel
diameters between the particles within the ecMNP250-filled chamber as compared to the
ecMNP600-filled one. This can result in shortened diffusion path and therefore better mass
transport [23]. An additional 40% increment was achieved using the 1:1 particle mixture, which
was obviously resulted as a synergy of the higher enzyme content (17%) due to the higher
chamber capacity and enhanced transport phenomena due to the small average microchan‐
nel diameter [25].
4.3. Testing multiple substrates in MagneChip
Substrate screening experiments were performed with a single ecMNP-loading in the chip
passing the solutions of the different substrates (Scheme 1: L-1a and rac-1b-f) through the same
chip according to a predefined sequence [22]. The intensive washing procedure between the
individual tests with various substrates ensured complete removal of any substrate or product
from the preceding cycle (reaction). In the first cycle, the ammonia elimination was meas‐
ured from L-1a (the natural substrate of PAL). This reaction was chosen as reference for
comparison to the other elimination reactions of PAL from the further substrates (rac-1b-f).
The difference between the initial and final (control) measurement with L-1a was found to be
only 1.5%, while the SC score remained below 2000. Surprisingly, in the MagneChip device,
higher biocatalytic activities (UB) were observed with four of the unnatural substrates
(rac-1b,c,e,f), than with the natural substrate L-phenylalanine L-1a (Figure 10).
Figure 10. Comparison of the specific biocatalytic activity of PcPAL immobilized on MNPs with substrates L-1a and
rac-1b-f in MagneChip system [(S) = 20 mM, flow rate: 48.6 μL min−1] [22]. *Control measurement.
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Noteworthy, all the four unnatural substrates (rac-1b,c,e,f) which were transformed by the
MNP biocatalyst with higher specific biocatalytic activity (UB) than that of L-phenylalanine
L-1a contained slightly more electron-withdrawing aromatic moieties than the phenyl group.
This difference from the productivity ranks observed with homogenous PcPAL so far may be
due to the reduced contribution of the reverse reaction (equilibrium effect) to the apparent
forward reaction rates in the continuous-flow system at high flow rates [22].
4.4. Characterization of an enzyme reaction with a novel substrate
By a reaction performed in the MagneChip device, it was first demonstrated that PAL can
catalyze the ammonia elimination from the acyclic DL-propargylglycine (PG) to yield (E)-
pent-2-ene-4-ynoate, indicating new opportunities to extend the MIO-enzyme toolbox toward
acyclic substrates. Deamination of PG, being acyclic, cannot involve a Friedel–Crafts-type
attack at an aromatic ring [18].
MagneChip, filled by PAL-ecMNPs, was used for the microscale biotransformation of DL-
propargylglycine in sodium carbonate-buffered D2O. The device enabled to detect the
formation of (E)-pent-2-en-4-ynoate at 242 nm and to produce measurable quantities of the
product for recording 1H-NMR spectra without any work-up. Besides the significant in‐
crease of the UV-signal at 242 nm (up to A = 1.2) in the in-line UV-cell (Figure 11), the
appearance of olefin hydrogen signals in the 1H-NMR spectrum of the reaction mixture [at δ
= 6.34 (d) and 6.85 (d) ppm] indicated unambiguously the formation of (E)-pent-2-en-4-ynoate.
On the other hand, emergence of the UV signal at 274 nm during the process indicated the
formation of further by-product(s) apart from (E)-pent-2-en-4-ynoate (Figure 11).
Figure 11. Ammonia elimination from DL-propargylglycine in MagneChip filled with PAL immobilized on MNPs and
equipped with in-line UV–Vis detector (reaction in D2O at pD 8.8, 37°C) [18]. The progress of the reaction was followed
by full UV-spectra.
5. Conclusion
Our results proved that the MagneChip microfluidic device is a reliable, reproducible, and
efficient tool which was capable of fast, reliable, and fully automated screening and kinetic
characterization of PcPAL substrates using minimal solvent (~500 μl) and biocatalyst (~1 mg
MNP) amounts for a test compound. Compared with shake vial, the volumetric productivity
of the MNP biocatalyst in the chip exceeded the one of the shake vial by more than three orders
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of magnitude. The platform was also capable of studying enzymatic reactions with undiscov‐
ered substrates of PcPAL. The above results suggest that the MagneChip platform would be
successfully utilized as a novel and flexible tool for enzyme-catalyzed biotransformations.
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